Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Mylan Health Pty Ltd (formerly BGP Products Pty Ltd) v Sun Pharma ANZ Pty Ltd (formerly Ranbaxy Australia Pty Ltd) (No 2) [2019] FCA 883 File number: NSD 532 of 2016
Judge: NICHOLAS J
Date of judgment: 12 June 2019
Catchwords: PATENTS – costs of patent proceeding – whether unsuccessful applicant (patentee) should be required to pay all of respondent's costs – where respondent unsuccessful on some issues – apportionment justified – applicant to pay 80% of respondent's costs
Legislation: Federal Court of Australia Act 1976 (Cth) s 43
Cases cited: Gray v Richards (No 2) (2014) 89 ALJR 113 Mylan Health Pty Ltd (formerly BGP Products Pty Ltd) v Sun Pharma ANZ Pty Ltd (formerly Ranbaxy Australia Pty Ltd) [2019] FCA 28 Ruddock v Vadarlis (No 2) (2001) 115 FCR 229
Date of hearing: Determined on the papers
Registry: New South Wales
Division: General Division
National Practice Area: Intellectual Property
Sub-area: Patents and associated Statutes
Category: Catchwords
Number of paragraphs: 16
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate